UCL Institute of Ophthalmology and Moorfields: Vacancy: Clinical Research Fellow

UCL Logo

27 February 2019
Source: Women in Vision UK

Position: Clinical Research Fellow, ref. 1794255  Hours: Full time Salary: £35,661 per annum (inclusive of London allowance) Location: London Closing date: 18 March 2019, 23:59 Interview date: tbc About You This is a unique opportunity for either an ophthalmology trainee, fellow, optometrist, orthoptist or nurse, but you have to enjoy writing on genetic eye disease for both lay people and health care professionals

Read more UCL Institute of Ophthalmology and Moorfields: Vacancy: Clinical Research Fellow

Moorfields and UCL Institute of Ophthalmology: Thinner retinas are an early sign of cognitive decline

26 July 2018
Source: Moorfields

Researchers from Moorfields and the UCL Institute of Ophthalmology (UCL IoO) have found that thinner retinas in the human eye are a clear sign a person is at significant and increased risk of future mental decline. This breakthrough study co-authored by Prof Paul Foster, Professor of Glaucoma Studies  at UCL IoO and Moorfields, and Mr Praveen Patel, consultant ophthalmic surgeon

Read more Moorfields and UCL Institute of Ophthalmology: Thinner retinas are an early sign of cognitive decline

UCL and Moorfields Eye Hospital launch design competition for new joint facility

8 June 2018
Source: Moorfields eye Hospital

Royal Institute of British Architects (RIBA) on behalf of UCL, Moorfields Eye Hospital NHS Foundation Trust and Moorfields Eye Charity have today launched a competition calling for multi-disciplinary design teams for a new joint eye care, research and education facility. It is proposed that all services provided at Moorfields Eye Hospital on City Road and the UCL Institute of Ophthalmology

Read more UCL and Moorfields Eye Hospital launch design competition for new joint facility

Fight for Sight/UCL Institute of Ophthalmology: Innovative therapy could treat patients with Fuchs endothelial corneal dystrophy

9 March 2018
Source: Fight for Sight

A proof-of-concept study carried out at UCL Institute of Ophthalmology with funding from Fight for Sight has highlighted the potential of a targeted antisense oligonucleotide (ASO) therapy to treat Fuchs endothelial corneal dystrophy patients with a mutation in the TCF4 gene. Results from the study are published this week in The American Journal of Human Genetics. Fuchs endothelial corneal dystrophy

Read more Fight for Sight/UCL Institute of Ophthalmology: Innovative therapy could treat patients with Fuchs endothelial corneal dystrophy